Potter Anderson Represents DuPont in Deal to Acquire Biotechnology Assets from Dyadic
DuPont Industrial Biosciences (DuPont) has signed an agreement to purchase enzyme and technology assets from Dyadic International, Inc., including Dyadic’s C1 platform, a fungal expression technology for producing enzymes. The transaction will further extend the world-leading biotechnology capabilities of DuPont’s Industrial Biosciences business. The transaction is expected to close in the fourth quarter 2015, subject to approval by Dyadic stockholders and customary closing conditions.
The Potter Anderson team is led by partners Michael B. Tumas and Roxanne L. Houtman.
Click here for more information.